Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1884 1
1944 1
1946 1
1948 1
1950 1
1951 1
1953 2
1954 1
1955 1
1956 1
1957 2
1958 1
1962 1
1964 1
1965 4
1966 3
1967 3
1968 1
1969 4
1970 1
1971 3
1973 3
1975 2
1976 4
1978 4
1979 5
1980 3
1981 7
1982 3
1983 8
1984 12
1985 11
1986 7
1987 12
1988 8
1989 8
1990 5
1991 12
1992 7
1993 13
1994 14
1995 25
1996 21
1997 12
1998 24
1999 19
2000 22
2001 20
2002 11
2003 22
2004 25
2005 27
2006 27
2007 38
2008 33
2009 48
2010 53
2011 66
2012 86
2013 82
2014 89
2015 89
2016 77
2017 61
2018 71
2019 66
2020 73
2021 74
2022 47
2023 60
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

1,394 results

Results by year

Filters applied: . Clear all
Page 1
A Chat(GPT) about the future of scientific publishing.
Hill-Yardin EL, Hutchinson MR, Laycock R, Spencer SJ. Hill-Yardin EL, et al. Among authors: hutchinson mr. Brain Behav Immun. 2023 May;110:152-154. doi: 10.1016/j.bbi.2023.02.022. Epub 2023 Mar 1. Brain Behav Immun. 2023. PMID: 36868432 Review. No abstract available.
Patellar Tendinopathy.
Schwartz A, Watson JN, Hutchinson MR. Schwartz A, et al. Among authors: hutchinson mr. Sports Health. 2015 Sep-Oct;7(5):415-20. doi: 10.1177/1941738114568775. Epub 2015 Jan 23. Sports Health. 2015. PMID: 26502416 Free PMC article. Review.
Small-Molecule Modulators of Toll-like Receptors.
Wang Y, Zhang S, Li H, Wang H, Zhang T, Hutchinson MR, Yin H, Wang X. Wang Y, et al. Among authors: hutchinson mr. Acc Chem Res. 2020 May 19;53(5):1046-1055. doi: 10.1021/acs.accounts.9b00631. Epub 2020 Apr 1. Acc Chem Res. 2020. PMID: 32233400 Review.
A new staging system for cardiac transthyretin amyloidosis.
Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN. Gillmore JD, et al. Among authors: hutchinson m. Eur Heart J. 2018 Aug 7;39(30):2799-2806. doi: 10.1093/eurheartj/ehx589. Eur Heart J. 2018. PMID: 29048471
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy.
Giles AJ, Hutchinson MND, Sonnemann HM, Jung J, Fecci PE, Ratnam NM, Zhang W, Song H, Bailey R, Davis D, Reid CM, Park DM, Gilbert MR. Giles AJ, et al. Among authors: hutchinson mnd. J Immunother Cancer. 2018 Jun 11;6(1):51. doi: 10.1186/s40425-018-0371-5. J Immunother Cancer. 2018. PMID: 29891009 Free PMC article.
How much is too much? (Part 2) International Olympic Committee consensus statement on load in sport and risk of illness.
Schwellnus M, Soligard T, Alonso JM, Bahr R, Clarsen B, Dijkstra HP, Gabbett TJ, Gleeson M, Hägglund M, Hutchinson MR, Janse Van Rensburg C, Meeusen R, Orchard JW, Pluim BM, Raftery M, Budgett R, Engebretsen L. Schwellnus M, et al. Among authors: hutchinson mr. Br J Sports Med. 2016 Sep;50(17):1043-52. doi: 10.1136/bjsports-2016-096572. Br J Sports Med. 2016. PMID: 27535991 Free PMC article.
How much is too much? (Part 1) International Olympic Committee consensus statement on load in sport and risk of injury.
Soligard T, Schwellnus M, Alonso JM, Bahr R, Clarsen B, Dijkstra HP, Gabbett T, Gleeson M, Hägglund M, Hutchinson MR, Janse van Rensburg C, Khan KM, Meeusen R, Orchard JW, Pluim BM, Raftery M, Budgett R, Engebretsen L. Soligard T, et al. Among authors: hutchinson mr. Br J Sports Med. 2016 Sep;50(17):1030-41. doi: 10.1136/bjsports-2016-096581. Br J Sports Med. 2016. PMID: 27535989
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group. Brown JWL, et al. Among authors: hutchinson m. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588. JAMA. 2019. PMID: 30644981 Free PMC article.
1,394 results